1 Sept 20251cites
Discovery of Furopyrimidine‐Pyrazole Hybrid Compounds Targeting p53‐MDM2 Interaction as Anticancer AgentsPublisher siteArchiv der Pharmazie, Cancer-related Molecular Pathways
UniversitiesGhaneya S. Hassan
Active, last published 2026
Ghaneya S.
Hassan
Scholar“Research profile drawn from open scholarly records.”
Cairo University
Claim Your Profile5
H-index
46
Citations
Ghaneya has not officially claimed their profile. If you are Ghaneya, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Ghaneya S. Hassan will appear here once their profile is updated.
02 · Reach
Publication output and reach
Ghaneya's work has been cited 46 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchCairo UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works26 Mar 2025Open access5cites
Insecticides and testicular health: mechanisms of injury and protective natural productsPublisher siteNaunyn-Schmiedeberg s Archives of Pharmacology, Pesticide Exposure and Toxicity
1 Feb 2025Open access7cites
Multi-stage structure-based virtual screening approach combining 3D pharmacophore, docking and molecular dynamic simulation towards the identification of potential selective PARP-1 inhibitorsPublisher siteBMC Chemistry, PARP inhibition in cancer therapy
20 Apr 2024Open access15cites
Probing benzenesulfonamide–thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase IIPublisher siteEuropean Journal of Medicinal Chemistry, Enzyme function and inhibition
4 Apr 20248cites
Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitorsPublisher siteBioorganic Chemistry, TGF-β signaling in diseases
15 Dec 202310cites
Phthalimide‐tethered isatins as novel poly(ADP‐ribose) polymerase inhibitors: Design, synthesis, biological evaluations, and molecular modeling investigationsPublisher siteArchiv der Pharmazie, PARP inhibition in cancer therapy
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ghaneya?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you